Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 1,493,679 |
|
|||||
| News | - | ||||||
| Day High | 13.91 | Low High |
|||||
| Day Low | 13.38 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sage Therapeutics Inc | SAGE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.11 | 0.81% | 13.69 | 17:38:40 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 13.87 | 13.38 | 13.91 | 13.69 | 13.58 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 17,149 | 1,493,679 | $ 13.69 | $ 20,450,283 | - | 10.92 - 59.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:05:33 | formt | 7,823 | $ 13.69 | USD |
Sage Therapeutics (SAGE) Options Flow Summary
Sage Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 821.66M | 60.11M | - | 86.46M | -541.49M | -9.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sage Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAGE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.93 | 14.97 | 12.7441 | 13.53 | 1,361,214 | 0.76 | 5.88% |
| 1 Month | 18.71 | 18.76 | 10.92 | 14.57 | 1,237,542 | -5.02 | -26.83% |
| 3 Months | 25.59 | 27.39 | 10.92 | 19.20 | 1,054,163 | -11.90 | -46.50% |
| 6 Months | 18.69 | 28.26 | 10.92 | 20.56 | 969,430 | -5.00 | -26.75% |
| 1 Year | 47.04 | 59.99 | 10.92 | 25.59 | 1,097,175 | -33.35 | -70.90% |
| 3 Years | 77.42 | 80.87 | 10.92 | 34.67 | 770,690 | -63.73 | -82.32% |
| 5 Years | 164.50 | 193.56 | 10.92 | 49.67 | 754,375 | -150.81 | -91.68% |
Sage Therapeutics Description
| Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. |
